Founded in 2018 and headquartered in Champaign, IL, SimBioSys is a precision cancer care company dedicated to enhancing personalized and patient-specific understanding of cancer through advanced technology. The company's core mission is to redefine precision medicine and revolutionize patient care by leveraging artificial intelligence and biophysical simulations. Their flagship product, TumorScope, uses standard diagnostic data to create spatially resolved virtual replicas of individual tumors, enabling more precise treatment planning and addressing tumor heterogeneity.
Notable figures associated with SimBioSys include Tushar Pandey, the Chief Executive Officer. The company has garnered attention for its innovative approach to cancer treatment, attracting significant interest from investors in the life sciences sector. Key achievements include the successful deployment of TumorScope in clinical settings, demonstrating improved outcomes in personalized cancer care. Overall, SimBioSys is making a substantial impact on the field of oncology by providing tools that allow for more accurate diagnosis and tailored treatment strategies.
SimBioSys' most recent funding round was for $5.2M (USD) in December 2024.
As of Dec 20, 2024, SimBioSys has disclosed funding of $20.2M (USD).

Massive Bio
massivebio.com

Vysioneer
vysioneer.com

OncoPrecision
oncoprecision.bio

Serinus Biosciences
serinus.bio

Onc.AI
onc.ai

SpIntellx
predxbio.com

First Ascent Biomedical
firstascentbio.com

Elephas
elephas.com

Noetik
noetik.ai

Encapsulate
encapsulate.bio

Insilicom
insilicom.com

Empiri
empiricancer.com

xCures
xcures.com

Predictive Oncology

BostonGene
bostongene.com

Isabl
isabl.io

ConcertAI
concertai.com

Triomics
triomics.com

SEngine Precision Medicine

InSyBio
insybio.gr